查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566929

急性缺血性脑中风诊断市场：按技术、最终用户划分：2024-2033 年全球机会分析与产业预测

Acute Ischemic Stroke Diagnosis Market By Technology , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3个工作天内

价格
简介目录

急性缺血性脑中风诊断市场

2023年，急性缺血性脑中风诊断市值为21亿美元，预计2024年至2033年复合年增长率为5.7%，到2033年将达到36亿美元。

急性缺血性脑中风（AIS）是一种致命的疾病，其中流向大脑的血液突然中断，导致神经功能障碍。闭塞通常是由血栓或栓子引起，导致脑组织缺血或梗塞。突然虚弱、说话或理解困难、身体一侧麻木、视力模糊、严重头痛和头晕是 AIS 最常见的症状。 AIS 的即时诊断需要临床评估和 CT 或 MRI 神经影像学检查，这对于及时恢復血流和减少脑损伤至关重要。

AIS 盛行率的不断上升，尤其是在老年人中，正在推动对急性缺血性脑中风诊断的需求。世界各地的老年人口正在迅速增加，生活方式的动态变化正在增加老年人中危及生命的疾病的发病率。此外，医疗保健和诊断技术支出的激增是市场的主要驱动因素。动脉自旋标记等非侵入性成像技术是 AIS 诊断的最新趋势。此类技术可以非侵入性地测量脑血流量，有助于透过快速、准确的诊断来评估组织活力。

然而，与这种尖端诊断技术相关的成本令人望而却步，阻碍了低收入者利用其优势并阻碍了市场开拓。此外，急性缺血性脑中风诊断的报销情况高度不一致且具有挑战性，限制了市场的成长。另一方面，政府为减少 AIS 盛行率所做的持续努力预计将为市场提供利润丰厚的机会。例如，欧洲中风组织于2018年发起了倡议，旨在2030年改善中风预防行为。

分部审查

急性缺血性脑中风诊断市场分为技术、最终用户和地区。依技术分为CT、MRI、颈动脉超音波、脑血管摄影、心电图、超音波心臟检查等。依最终使用者分类，可分为医院/诊所、门诊手术中心、诊断实验室/影像中心等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从技术角度来看，CT（电脑断层扫描）领域将在2023年占据较高的市场份额。

按最终用户划分，医院和诊所部门将在 2023 年成为最大股东。

按地区划分，预计到 2023 年，北美地区的收益最高。

可以自订此报告（需要额外的成本和时间表）。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章急性缺血性脑中风诊断市场：依技术分类

  • 市场概况
  • 电脑断层扫描
  • 磁振造影
  • 颈动脉超音波
  • 脑血管摄影
  • 心电图
  • 心臟超音波图
  • 其他的

第五章急性缺血性脑中风诊断市场：依最终用户分类

  • 市场概况
  • 医院和诊所
  • 门诊手术中心
  • 诊断实验室和诊断影像中心
  • 其他的

第六章急性缺血性脑中风诊断市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国急性缺血性脑中风诊断市场
    • 加拿大急性缺血性脑中风诊断市场
    • 墨西哥急性缺血性脑中风诊断市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国急性缺血性脑中风诊断市场
    • 法国急性缺血性脑中风诊断市场
    • 英国急性缺血性脑中风诊断市场
    • 义大利急性缺血性脑中风诊断市场
    • 西班牙急性缺血性脑中风诊断市场
    • 其他欧洲国家缺血性中风诊断市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本急性缺血性脑中风诊断市场
    • 中国急性缺血性脑中风脑中风诊断市场
    • 印度缺血性中风诊断市场
    • 澳洲缺血性中风诊断市场
    • 韩国急性缺血性脑中风诊断市场
    • 其他亚太地区缺血性中风诊断市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西缺血性中风诊断市场
    • 沙乌地阿拉伯缺血性中风诊断市场
    • 南非缺血性中风诊断市场
    • 其他拉丁美洲/中东/非洲急性缺血性脑中风诊断市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Koninklijke Philips NV
  • GE Healthcare
  • Canon Inc.
  • Simens
  • Terumo Corporation
  • Stryker
  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd
  • F. Hoffmann-La Roche Ltd
  • Boehringer Ingelheim International GmbH
简介目录
Product Code: A323961

Acute Ischemic Stroke Diagnosis Market

The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.

Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.

However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.

Segment Review

The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.

Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.

Region wise, North America is poised to be the highest revenue generator by 2023.

Competition Analysis

The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technology

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Laboratories and Imaging Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Koninklijke Philips N.V.
    • GE Healthcare
    • Canon Inc.
    • Simens
    • Terumo Corporation
    • Stryker
    • Fujifilm Holdings Corporation
    • Samsung Electronics Co. Ltd
    • F. Hoffmann-La Roche Ltd
    • Boehringer Ingelheim International GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technology
  • 4.2. Computed Tomography
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Magnetic Resonance Imaging
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Carotid Ultrasound
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Cerebral Angiography
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Electrocardiography
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Echocardiography
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Diagnostic Laboratories And Imaging Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Technology
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
      • 6.2.5.1. Market Size and Forecast, By Technology
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
      • 6.2.6.1. Market Size and Forecast, By Technology
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
      • 6.2.7.1. Market Size and Forecast, By Technology
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Technology
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
      • 6.3.5.1. Market Size and Forecast, By Technology
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Acute Ischemic Stroke Diagnosis Market
      • 6.3.6.1. Market Size and Forecast, By Technology
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
      • 6.3.7.1. Market Size and Forecast, By Technology
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
      • 6.3.8.1. Market Size and Forecast, By Technology
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
      • 6.3.9.1. Market Size and Forecast, By Technology
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
      • 6.3.10.1. Market Size and Forecast, By Technology
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Technology
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
      • 6.4.5.1. Market Size and Forecast, By Technology
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Acute Ischemic Stroke Diagnosis Market
      • 6.4.6.1. Market Size and Forecast, By Technology
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Acute Ischemic Stroke Diagnosis Market
      • 6.4.7.1. Market Size and Forecast, By Technology
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
      • 6.4.8.1. Market Size and Forecast, By Technology
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
      • 6.4.9.1. Market Size and Forecast, By Technology
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
      • 6.4.10.1. Market Size and Forecast, By Technology
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Technology
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
      • 6.5.5.1. Market Size and Forecast, By Technology
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
      • 6.5.6.1. Market Size and Forecast, By Technology
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
      • 6.5.7.1. Market Size and Forecast, By Technology
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
      • 6.5.8.1. Market Size and Forecast, By Technology
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. GE Healthcare
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Canon Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Simens
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Terumo Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Fujifilm Holdings Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Samsung Electronics Co. Ltd
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. F. Hoffmann-La Roche Ltd
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Boehringer Ingelheim International GmbH
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments